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Abstract
Aim: The relationship between arrhythmia induction and ablation with palpitation characteristics has been demonstrated in electrophysiological study (EPS) patients. However, there is insufﬁcient data on palpitation characteristics and
their sensitivity and speciﬁcity. We aimed to identify the relationship between scoring composed of palpitation characteristics with the supraventricular tachycardia (SVT) induction and the success rate of the procedure.
Method: A total of 119 patients, diagnosed as paroxysmal supraventricular tachycardia (PSVT) by electrocardiography,
rhythm Holter or symptoms, and underwent EPS, were enrolled in the study. A psychiatrist administered the Hospital
Anxiety and Depression Score (HADS) questionnaire.
Results: In SVT induced group, palpitation duration (p ¼ 0.048), palpitation spread to neck (p ¼ 0.004), responsiveness
to medication (p ¼ 0.008), induction with stress (p ¼ 0.007), admission to emergency (p ¼ 0.021) and documented PSVT
(p ¼ 0.017) were more common. Atropine administration (p ¼ 0.001) was higher, and the Wenckebach cycle length
(p < 0.001) was longer in the non-induced arrhythmia group. The presence of dual AV pathways was higher in SVT
induced group (p ¼ 0.002). There were no differences between groups in terms of anxiety score (p ¼ 0.192), depression
score (p ¼ 0.730), and total psychiatric results (p ¼ 0.280) in the HADS questionnaire. In scoring designed by the
palpitation characteristics, the score of four and over predicted SVT induction with 63.6% sensitivity and 92.5% speciﬁcity. Radio-frequency ablation (RFA) was performed succesfully in 82.1% of patients with a score of ≥4.
Conclusion: Supraventricular tachycardia induction score obtained from the palpitations characteristics and arrhythmia
documentation can be useful in predicting the induction of SVT and the success of RFA.
Keywords: Electrophysiological study, Supraventricular tachycardia induction, Radio-frequency ablation, Documented
arrhythmia, Palpitation

1. Introduction

P

alpitation is a common complaint in patients
presenting to the cardiology clinic. The
complaint of palpitation caused by arrhythmias is

usually due to paroxysmal supraventricular tachycardias (PSVT). Supraventricular tachycardias (SVT)
include atrioventricular nodal reentrant tachycardia
(AVNRT), atrioventricular reentrant tachycardia
(AVRT) and atrial tachycardia. Although these
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arrhythmias do not increase cardiovascular mortality, recurrent attacks affect patient's quality of life
[1,2].
Electrophysiological study (EPS) is an effective
procedure in the treatment of PSVT. In a majority of
the patients undergoing EPS, palpitation complaints
due to PSVT are permanently terminated by successful radio-frequency ablation (RFA) with a low
complication rate [3]. So, in the current guideline,
ablation is recommended with a class-I indication
for the treatment of PSVT [4].
Paroxysmal SVT is commonly diagnosed by
recording the patient's electrocardiogram (ECG) at the
time of palpitation or less often by rhythm Holter recordings. Patients with nondocumented PSVT may be
misdiagnosed as panic disorder. Unfortunately, the 24h rhythm Holter record used to document arrhythmias
is very low in terms of sensitivity and speciﬁcity in the
diagnosis [5,6]. Another alternative method to diagnose the possible PSVT is a loop recorder. The
effectiveness of this device is higher than the 24-h
rhythm Holter recording, but it is time-consuming and
rather expensive. Also, in studies using the event
recorder, clinically signiﬁcant arrhythmias could not
be detected in at least half of the patients [7].
Medical history, symptoms, and physical examination are the basis of clinical practice and are accessible.
The presence of palpitation complaint may be helpful
in diagnosis even if the arrhythmia could not be
documented. There is a relation between arrhythmia
induction in EPS and the characteristics of the palpitations. However, the sensitivity and speciﬁcity of the
relationship between SVT induction and characteristics of palpitation were not established [7e9].
We aimed to demonstrate the efﬁcacy of the
scoring system created by palpitation characteristics
for predicting the necessity for SVT induction and
RFA in EPS.

2. Method
2.1. Study Population
The current research is a cross-sectional study
that included 119 consecutive patients who underwent EPS between March 2017 and April 2018. Patients were diagnosed as PSVT by ECG, rhythm
Holter, or clinically. The study was performed under
the principles stated in the Declaration of Helsinki.
The local ethics committee approved the study
protocol, and patients gave informed consent.
We created a medical history form for the patients. By adhering to this form the characteristics of
arrhythmia - history and frequency of palpitation,
response to anti-arrhythmic drugs, sudden onset
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and termination of palpitation, palpitation spread to
the neck, emergency admission due to palpitation,
triggering with stress, vagal maneuver response
(straining, coughing) and history of syncope - were
questioned and recorded. With a total score of 6, we
gave 1 point to each of the variables that made up
the Arrhythmia Inducibility Prediction Score (AIPS),
based on its presence in the patient. Patients with
2 of these features and presented with palpitation
were accepted as clinical PSVT. We compared patients with a score of 2 or over and with a score of 4
or over according to prediction of SVT inducibility
and need for RFA. Electrophysiology study was not
performed in patients with less than two arrhythmia
characteristics.
ECG or rhythm Holter recordings with a heart
rate >100 bpm, a QRS duration of <120 ms, and
lasted for at least 30 s were accepted as documented
PSVT.
2.2. Exclusion Criteria
Patients with preexcitation on ECG, a basic
rhythm other than sinus rhythm before EPS, a history of broad QRS tachycardia or atrial ﬁbrillation, a
history of ablation therapy, congenital heart disease,
moderate or severe valve disease, severe left ventricular systolic dysfunction, permanent cardiac
pacemaker, intracardiac deﬁbrillator, cardiac
resynchronization therapy device, chronic renal
failure, endocrine disorder, malignancy, acute coronary syndrome, infectious and inﬂammatory disease, pulmonary embolism, severe comorbid
disease were excluded from this study.
2.3. Electrophysiological Study
In the anti-arrhythmic usage, drugs were discontinued for at least four half-lives before the
procedure. The femoral vein was the access path.
Unfractionated heparin (2500 IU) was administered
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Table 1. Baseline characteristics data of both groups.
Age, years
Age of ﬁrst palpitation attack, years
Women, n (%)
Hypertension, n (%)
Dyslipidemia, n (%)
Tobacco use, n (%)
Family arrhythmia history, n (%)

Inducible arrhythmia (n ¼ 66)

Non-inducible arrhythmia (n ¼ 53)

p value

50.6 ± 14.6
37.6 ± 14.8
41 (62.1)
25 (37.9)
8 (12.1)
7 (10.6)
3(4.5)

46.9 ± 18.3
39.9 ± 16.6
31 (58.5)
17 (32.1)
6 (11.3)
6 (11.3)
3(5.7)

0.534
0.718
0.687
0.510
0.893
0.901
0.782

after insertion of the catheters. 7-Fr decapolar 2 mm
electrode spacing (The Marinr™ CS, Medtronic)
catheter was placed to the coronary sinus, three 6-Fr
2 mm electrode spacing 1.3 mm electrode length
quadripolar (The Soloist™, Medtronic) catheter was
placed to the high right atrium, his bundle, and
right ventricle respectively. The intracardiac electrocardiographic recordings were monitored at
100 mm/s through the EP-Tracer®. Atrium-His (AH), His-ventricle intervals (HeV), and basal cycle
length (BCL) were measured before stimulation.
Atrioventricular refractory period (Wenckebach
cycle length) was determined by atrial overdrive
pacing. For arrhythmia induction, programmed
stimulation was performed from the upper right
atrium, right ventricle, distal, and proximal coronary
sinus. Stimulation protocol consisted of atrial and
ventricular incremental pacing, programmed atrial,
and ventricular extra-stimulus. When tachycardia
induced its refractor premature ventricular
contraction, ventricular overdrive pacing was performed to make a differentiation diagnosis. Atropine was administered to patients with
noninducable SVT. After atropine administration,
stimulation was repeated. Atropine dose was
titrated until the basal heart rate increased by 50%,
or the heart rate was between 100/bpm to 150/bpm.
Supraventricular tachycardia induced patients
(diagnosed as AVNRT, AVRT, atrial tachycardia)
were differentially diagnosed by atrial, ventricular,
and His pacing maneuvers.

Multicurve ablation catheter (4 mm) and Medtronic ablation system (Marinr ®; Medtronic Inc.,
Minneapolis, MN, USA) as RF generator were used.
Also, irrigation catheters, cryoablation, and electromechanical mapping systems were used where
necessary.
Radio-frequency ablation was performed according to one of the following criteria: 1. Patients with
induced SVT and differentially diagnosed in EPS. 2.
Patients with narrow QRS SVT recording in ECG or
rhythm Holter and had dual physiology with no
inducible arrhythmia. 3. Patients with the presence
of an accessory pathway, although no arrhythmia
could be induced.
Induced tachycardias were considered as supraventricular tachycardias if they met the following
criteria: 1) Heart rate >100 bpm, 2) Lasting over 30 s,
3) Regular AeA interval, 4) QRS duration <120 ms.
Repeated SVT induction with programmed stimulation or arrhythmia stimulation by an accessory
pathway was accepted as RFA criteria. No re-induction of arrhythmia, loss of an accessory pathway,
and loss of dual AV node physiology were accepted
as successful RFA.
Dual AV node physiology: Over 50 msec increase
in A2H2 interval with 10 msec decrease in A1A2
interval over 50 ms increase in AH interval with
10 ms decrease in atrial pacing rate. Double
response: Two ventricular responses to a single
atrial activation due to simultaneous fast - and slow
- pathway conduction.

Table 2. Study parametersin electrophysiology for both group.
Pre-inductive sedation, n (%)
Pre-inductive atropine, n (%)
Basal cycle length, ms
Atrium-His length, ms
His-Ventricul length, ms
Wenckebach point, ms
Dual atrioventricular pathway, n (%)
Atrium-His interval jump, n (%)
Bold numbers show statistical signiﬁcance.

Inducible arrhythmia (n ¼ 66)

Non-inducible arrhythmia (n ¼ 53)

p value

10 (15.2)
17 (27.8)
750 ± 125.6
56.5 ± 12.6
51.4 ± 8.8
302.849.2
40 (60.6)
29 (43.9)

5 (9.4)
29 (54.7)
748.4 ± 142.8
62.7 ± 17.9
50 ± 8.6
338.9 ± 40.4
17 (32.2)
16 (30.2)

0.350
0.001
0.954
0.074
0.462
<0.001
0.002
0.124

Table 3. Anxiety, depression and top score association of arrhythmia inducibility and EP success.

Anxiety score
Depression score
Total score

Inducible
arrhythmia
(n ¼ 56)

Non-inducible
arrhythmia
(n ¼ 35)

p value

Successful ablation
in EP (n ¼ 61)

No ablation in
EP (n ¼ 26)

Unsuccessful ablation
in EP (n ¼ 4)

p value

10.2 ± 4.4
7.3 ± 3.2
17.5 ± 6

8.9 ± 4.4
7.1 ± 3.4
16 ± 7

0.192
0.73
0.28

10.2 ± 4.3
7.1 ± 3.1
17.4 ± 5.9

8.9 ± 4.5
7.3 ± 3.8
16.3 ± 7.6

6.5 ± 5.5
7.8 ± 3.7
14.3 ± 7.3

0.101
0.694
0.313

2.4. Hospital Anxiety and Depression Scale
The HADS (Hospital Anxiety and Depression
Scale) was used to differentiate whether the palpitation was arrhythmic or psychological [10,11].
Surveys with standard questions were given to patients before EPS. Ninety-one of 119 participants
accepted the HADS questionnaire and surveyed.
The psychiatrist evaluated the answers to the HADS
questionnaire and rated the patient's anxiety and
depression scores.
2.5. Statistical Analysis
Continuous variables were presented as
mean ± standard deviation, and categorical variables were presented as percentages. The variables
were investigated using visual (histograms, probability plots) and analytical methods (KolmogoroveSmirnov/ShapiroeWilk's test) to determine
whether or not the data are normally distributed.
The Student t-test was used to compare these parameters among the inducible arrhythmia groups.
The ManneWhitney U-test tests were used for nonnormally distributed data. A p-value of less than
0.05 was considered to show a statistically signiﬁcant
result. Cross-tabulations were used for comparison
of the proportions of patients with categorical variables. The Chi-square or Fisher's exact test (when

chi-square test assumptions do not hold due to low
expected cell counts) was used to compare in
different groups. A p-value of less than 0.05 was
considered to show a statistically signiﬁcant result.
Statistical analyses were performed using the SPSS
software (Version 14.0, SPSS, Inc., Chicago, IL).

3. Results
Patients were divided into two groups according
to SVT inducibility. Supraventricular tachycardia
was induced in 66 (55%) of 119 patients. Most of the
patients were women (60%) and there was no difference in demographic characteristics of the groups
(Table 1).
In SVT induced group, 52 of them had AVNRT, 11
had atrial tachycardia, and three had AVRT. Seventy-four patients underwent ablation during the
EPS procedure and successful ablation was achieved in 70 of them. In eight patients with noninducible arrhythmia, due to documented SVT and
complain of palpitation, slow pathway ablation was
performed as a result of EPS ﬁndings (jump, etc.).
Atropine administration (p ¼ 0.001) was higher
and Wenckebach cycle length (p < 0.001) was longer
in patients with non-induced arrhythmia group.
Presence of dual AV node pathway was higher in
SVT induced group (p ¼ 0.002) (Table 2).
Anxiety score, depression score, and total psychiatric results were similar between the groups (Table

Table 4. Palpipation characteristics data of both groups.

Sudden onset palpitation n (%)
Sudden offset palpitation n (%)
Palpitation duration<5 min, n (%)
Palpitation duration 5 min, n (%)
Palpitation spread to neck,n (%)
Responsiveness to medication, n (%)
Responsiveness to vagal maneuvers, n (%)
Syncope,n (%)
Documented supraventricular
tachycardia, n (%)
Admission to emergency, n (%)
Stress* induced, n (%)
Regularity of palpitation, n (%)

Inducible
arrhythmia (n ¼ 66)

Non-inducible
arrhythmia (n ¼ 53)

p value

39
25
32
36
32
29
10
20
47

(51.9)
(37.9)
(48.5)
(51.5)
(48.5)
(43.9)
(15.2)
(30.3)
(71.2)

24 (45.3)
17 (32.1)
37 (69.8)
16 (30.2)
12 (22.6)
11 (20.8)
5 (9.4)
16 (30.2)
26 (49.1)

0.134
0.510
0.048
0.004
0.008
0.350
0.989
0.017

46 (69.7)
39 (59.1)
26 (39.4)

24 (45.3)
20 (37.7)
13 (24.4)

0.007
0.021
0.086

Palpitation complaint triggered by emotional or physical stress.
Bold numbers show statistical signiﬁcance.
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_
Table 5. Arrhythmia inducibility prediction score (AIPScore).
Score
Palpitation duration >5 mn
Palpitation spread to neck
Responsiveness to medication
Documented supraventricular tachycardia
Admission to emergency
Stress induced
Total

1
1
1
1
1
1
6

3). Duration of palpitation (p ¼ 0.048), spreading of
palpitation to neck (p ¼ 0.004), response to medication (p ¼ 0.008), documented SVT (p ¼ 0.017), history
of admission to emergency (p ¼ 0.021) and stresstriggered palpitation (p ¼ 0.007) were more common
in SVT induced group (Table 4).
We created a scoring to predict the inducible SVT
with parameters signiﬁcant in terms of palpitation
characteristics (Table 5). Scoring was arranged to be
a minimum of zero and a maximum of six points.
Induction of SVT was statistically high in patients
scoring four or over (Table 6). The sensitivity of the
scoring was 63.6%, and speciﬁcity was 92.5% for
inducing SVT. The sensitivity of arrhythmia induction of patients with Arrhythmia Inducibility Prediction Score (AIPS) 2 was 65.3%, and speciﬁcity
was 59.6%, while the sensitivity of patients with
AIPS 4 was 63.6%, and speciﬁcity was 92.5%.
Succesfull ablation for patients with AIPS 4 was
82.1%, while it was 69.4% for patients with AIPS 2.
We can emphasize that the higher the AIPS, the
better the speciﬁcity of SVT induction and performing ablation (Table 7).

4. Discussion
Characteristics of the palpitation such as duration
>5 min, spreading to the neck, responsiveness to
medication, documentation, triggering with stress
were signiﬁcantly more common in SVT induced
group. As a result of the scoring consisted of using
these criteria, score of four or over predicted SVT
induction with 63.6% sensitivity and 92.5% speciﬁcity and predicted successful ablation with 82.1%.
As the AIPS increased, the speciﬁcity of SVT induction and the necessity of ablation increased.
Although our study patients had recurrent hospital
_
Table 6. Arrhythmia Inducibility Prediction Score (AIPScore)
data of all
patients.

AIPScore <4
AIPScore 4
AIPScore

Inducible
arrhythmia
(n ¼ 66)

Non-inducible
arrhythmia
(n ¼ 53)

p value

24 (36.4)
42 (63.6)
3.9 ± 1.9

49 (92.5)
4 (7.5)
1.98 ± 1.9

0.001
<0.001

admissions due to palpitations, our SVT induction
rates lagged behind the literature (55 vs. 90%) [4].
We think that this group of patients we often
encounter in the clinic may reﬂect the real-world
data. The current study demonstrates the importance of careful questioning of the palpitation
characteristics when selecting patients for EPS. This
result is revealed in the literature for the ﬁrst time.
Many studies have tried to reveal the clinical
features of PSVT. Mayou et al. showed that the
duration of palpitation and intense physical activity
had a relationship with arrhythmia [12]. Bunch et al.
demonstrated that the incidence of atrial arrhythmia
increased with exercise [13]. In the present study,
exercise and emotional stress appeared to be related
with SVT induction. The relation was likely due to
increased adrenergic stimulation with exercise and
emotional stress [14].
Documented PSVT is one of the essential clinical
basis for EPS [15]. However, documentation alone
may not identify patients who can be treated by RFA.
Previous research in our clinic revealed the importance of palpitation characteristics. In the study
mentioned above, arrhythmia induction and RFA
rates were found to be similar in patients with clinical
PSVT to patients with documented PSVT [8]. In the
present study, sudden onset and end of a palpitation,
response to vagal maneuver, and regularity were
found to be more frequent in the SVT induced group,
but there was no statistical signiﬁcance. The presence
of documented PSVT did not reach a signiﬁcancy in
patients with induced SVT, but it tended to be common in this group (Table 1). Although the two clinical
trials show a statistical inconsistency, the results
support each other. This difference seems to be
related to the number of patients included and the
demographic characteristics.
Gonzalez-Torrecilla et al. found that age, female
gender, and neck palpitation had a relationship with
AVNRT induction in patients who underwent EPS
procedure. However, only the neck palpitation was
an independent predictor for AVNRT [16]. Laurent
et al. conﬁrmed the association of neck palpitation
frequency with AVNRT [17]. In the current study,
the palpitation spread to the neck was correlated to
the induction of SVT, and the result was consistent
with the other studies.
Psychiatric or cardiac causes may cause palpitation complaints [7]. Various psychiatric scoring
systems have been established besides routine examinations to test whether the symptoms of palpitations are psychiatric or cardiac. One of these
scoring systems is the Hospital Anxiety and
Depression Scale (HADS), which guides on whether
patient's current complaints are based on an organic

0.289
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cause.[10] In a review of 747 studies, HADS performed efﬁciently in evaluating the severity of anxiety disorders and depression in both somatic and
psychiatric cases.[11] Kitzlerov
a et al. found no difference in psychiatric measures evaluating anxiety
and depression in a study comparing healthy subjects with PSVT patients [18]. In the present study,
the anxiety and depression score obtained as a
result of the HADS questionnaire was similar in
both groups, as the stated study.
Lessmeier et al. reported that panic attack-like
symptoms could mask arrhythmia in patients with
PSVT attacks, and this might cause a missed diagnosis [19]. Eaker et al. showed the association of
anxiety and depression with atrial ﬁbrillation (AF)
occurrence [20]. Lange et al. observed that relapse
was more familiar with depressive symptoms during follow-up of patients who underwent cardio€
version for AF [21]. Ozlü
et al. reported that for
patients who underwent EPS due to non-documented palpitation, arrhythmia induction correlated
with low quality of life and high anxiety levels [11].
In all these studies, psychiatric symptoms had association with arrhythmia. In the present study, the
anxiety and depression score was statistically
similar between the groups. The reason for the
contradiction might be that all patients did not
participate in the psychiatric questionnaire. Studies
have shown that atrioventricular refractory cycle
length (Wenckebach cycle) has an inverse relationship with arrhythmia induction in EPS [22]. Our
ﬁndings support this result.
Although RFA has a low complication and high
success rate, patients with documented arrhythmia
are preferred in the indication process of PSVT. This
may be due to the economic cost of the procedure
and the concern of cardiologists for making unnecessary interventional procedures. The induction of
SVT plays a critical role in successful ablation, and
the general thought is that the induction of patients
with documented PSVT will be easier, and ablation
will be more successful. However, this approach
may lead to insufﬁcient treatment in patients with
non-documentable PSVT. Although used in routine
clinics, the rate of detecting arrhythmia by rhythm
Holter is low in patients presenting with palpitations [23,24]. The results of the study are essential to
show the role of the data obtained from the anamnesis. The AIPS may play an active role in identifying patients who will beneﬁt from EPS or RFA.
Given the limited number of patients, large patientvolumed trials can make this scoring system more
sensitive and speciﬁc. Thus, patients with nondocumented PSVT can be more accurately detected
and treated based on their symptoms.
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0.004

0.004

27 (57.4)
22 (30.6)
44 (48.4)
5 (17.9)
(42.6)
(69.4)
(51.6)
(82.1)
0.029 20
50
0.005 47
23
20 (71.4)
7 (38.9)
27 (65.9)
0
8 (28.6)
11 (61.1)
14 (34.1)
5 (100)
0.459

7 (36.8)
15 (27.8)
17 (34)
5 (21.7)
(63.2)
(72.2)
(66)
(78.3)
AIPScore<2 12
AIPScore 2 39
AIPScore<4 33
AIPScore 4 18

0.027

No or Unsuccessful ablation p value Successful ablation (n ¼ 19) No or Unsuccessful ablation p value Successful ablation (n ¼ 70) No or Unsuccessful ablation p value
(n ¼ 22)
(n ¼ 27)
(n ¼ 49)
Successful
ablation
(n ¼ 51)

0.001

0.001

28 (59.6)
25 (34.7)
49 (92.5)
4 (7.5)
(40.4)
(65.3)
(36.4)
(63.6)
0.005 19
47
0.005 24
42
21 (75)
6 (33.3)
27 (65.9)
0
7 (25)
12 (66.6)
14 (34.1)
5 (100)
0.897

7 (36.8)
19 (35.2)
22 (44)
4 (17.4)
(63.2)
(64.8)
(56)
(82.6)
AIPScore<2 12
AIPScore 2 35
AIPScore<4 28
AIPScore 4 19

p value Inducible arrhythmia
(n ¼ 19)
P value Inducible
arrhythmia
(n ¼ 19)
Inducible Non-inducible
arrhythmia arrhythmia
(n ¼ 47)
(n ¼ 26)

Undocumented SVT
Documented SVT

Table 7. Arrhythmia Inducibility Prediction Score (AIPScore) data of both groups.

Non-inducible arrhythmia
(n ¼ 27)

Total

Non-inducible arrhythmia
(n ¼ 27)

p value
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5. Limitation
A relatively small number of patients is the main
limitation. Some patients did not accept a psychiatric questionnaire. Isoproterenol is often used to
induce arrhythmia. That isoproterenol could not be
used in the study might have resulted in a lower rate
of SVT induction. Furthermore, the presence of
AVRT in a small proportion of induced SVT makes
it inadequate to demonstrate the efﬁcacy of AIPS in
this condition. Additionally, poor sensitivity of low
scores (<4) may weaken the use of AIPS in the clinic.
Further studies are needed to check and improve
the accuracy of the results.

6. Conclusion
Palpitation duration >5 min, palpitation spreading
to the neck, responsiveness of arrhythmia to medication, documented SVT, stress-triggered palpitation
were more common in the SVT induced group. As a
result of the scoring formulated by using these criteria,
the score of four or over predicted SVT induction with
63.6% sensitivity and 92.5% speciﬁcity and predicted
the successful ablation with 82.1%. The scoring system
can help in the decision to perform EPS. Before the
present data are used in clinical practice, they need to
be ascertained by independent investigators in other
cohorts with similar characteristics.
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